Main Newsletter
Mastery Series
Therapy Series
 
Letter From The Editor

When we see older men with diabetes in the office we often see the change in muscle mass and our first thought is to check testosterone levels. For many of these seniors the levels are acceptable and we just attribute the decline to their advancing age. But now a new study has found that a decrease in protein consumption may be causative. When researchers compared patients on 10% vs 17% protein diets, they found that the men on the lower protein diet had less muscle mass and more catabolism. In fact, although these patients could adapt to a lower protein diet they were not able to reach nitrogen equilibrium and so muscle was lost. This gives you an additional reason to encourage your patients to start their day out with 25-30 grams of protein.

Many of us remember a drug called Galvus that almost made it to the market in the U.S. This was Novartis' brand name for their DPP-4 inhibitor which was at least a year ahead of the first approved drug in that class, Januvia. The FDA withheld approval, however, because of skin lesions in monkeys. There was a lot of talk in the medical community that it was because DPP-4 and other DPP inhibitors might have a negative effect on other organs in the body. A new study from the United Kingdom Clinical Practice Research Datalink has examined the potential negative effects that DPP-4 inhibitors might or might not have.

*****

Announcements:

dLifeTV.com: Sunday, February 1, 7PM ET

From dLife.com: "dLife brings you the harrowing story of Ernest Sterzer, a type 1 teenage who survived the unthinkable in Nazi Germany. Also, a special tribute to the late, great sports legend, Ron Santo." Sundays live online at dLifeTV.com at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at dLifeTV.com
 
*****************************

We can make a difference!

*****************************

Dave Joffe, Editor-in-chiefRead More

Scroll down for items in the current newsletter

Tool for your Practice

 

We've recently updated this important list which includes dosing range, average lowering of LDL, side effects and generic availability. Download the PDF (4 pages) and post in your office today: Cholesterol-Lowering Treatment Options.




Product of the Week

 

The FDA has approved Dexcom's G4 PLATINUM Continuous Glucose Monitoring System with Share. The Dexcom Share receiver uses a secure wireless connection via Bluetooth Low Energy (BLE) between a patient's receiver and an app on the patient's smartphone to transmit glucose information to apps on the mobile devices of up to five designated recipients, or "followers," without the need for a dedicated docking cradle. These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere, initially via their Apple iPhone or iPod touch and in the future on Android devices, giving them peace of mind and reassurance when they are apart. The "Share" and "Follower" apps will be available early March 2015 on the Apple App Store at no charge.

 

Mobile App of the Week

Foodily

Foodily is a great app to recommend to your patients who are looking for a little creative inspiration in their diets. The website the app taps into is the world's largest social recipe network where they can discover and share any recipe on the web, including their own. They can track their favorites and follow both friends and experts like Wolfgang Puck and Cat Cora. Just follow this link for more information and to download the app.

 

 

 

 

Test Your Knowledge Question #766

Statin drugs are classified under which FDA pregnancy category:

a. Category C
b. Category E
c. Category X

For the complete question and answer, just follow this link. 

 

Diabetes In Control Has Over 15000 Studies & Articles In Our Archives

Quote of the Week!

"It is health that is real wealth and not pieces of gold and silver."
                                                             ...Mahatma Gandhi

 

 

Diabetes in Control gratefully acknowledges the assistance of the following  pharmacy doctoral candidates in the preparation of this week's newsletter: 

Kelly Tran, LECOM College of Pharmacy
Samuel Moon, LECOM College of Pharmacy

 


Cast Your Vote
Will you prescribe inhaled insulin (Afrezza) when it becomes available this year?
CME/CE of the Week
Joy Pape, RN, BSN, DE, WOCN, CPT 

Category: Nursing
Credits: .75


Advertisement


Search Articles On Diabetes In Control